Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1496, 2005-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Multiple Drug Targets in the Management of Type 2 Diabetes
Current Drug Targets, Vol. 3, Iss. 3, 2002-06 ,pp. :
Access to resources
Recommend
Losartan: real benefits in RENAAL disease for patients with type 2 diabetes
Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. :
GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges
Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. :
Benefits and Risks of Transfer from Oral Agents to Insulin in Type 2 Diabetes Mellitus
Drug Safety, Vol. 21, Iss. 1, 1999-07 ,pp. :